DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...

Northwell Health is now offering a new injection that promises to reduce the risk of HIV and AIDS. Doctors say it will combat ...

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

Yeztugo, a twice yearly injection, offers a promising advancement in HIV prevention, but high costs and insurance uncertainties may limit its accessibility.

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Patients are already receiving the new PrEP injectable option lenacapavir in the Bay Area, though issues with insurance are ...

"To prevent HIV right now, we essentially have to give someone a daily pill. And, frankly, we haven't had the uptake of a daily pill. 2.5 million people need to be on PrEP, we only have about ...

The U.S. Food and Drug Administration (FDA) has approved the first-ever long-acting injectable drug for HIV prevention.. Until this week, the only FDA-licensed and approved medications for HIV pre ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

Oral PrEP is a regimen most commonly taken as one pill per day to help prevent at-risk persons from contracting HIV. Those considered at-risk are people who are HIV-negative but may have other ...

PrEP drugs are cheap and save the U.S. health care system billions of dollars, according to the Centers for Disease Control and Prevention, as The Atlanta Journal-Constitution has previously reported.